116 related articles for article (PubMed ID: 12543780)
1. Prolonged treatment with angiostatin reduces metastatic burden during radiation therapy.
Gorski DH; Mauceri HJ; Salloum RM; Halpern A; Seetharam S; Weichselbaum RR
Cancer Res; 2003 Jan; 63(2):308-11. PubMed ID: 12543780
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin.
Gorski DH; Mauceri HJ; Salloum RM; Gately S; Hellman S; Beckett MA; Sukhatme VP; Soff GA; Kufe DW; Weichselbaum RR
Cancer Res; 1998 Dec; 58(24):5686-9. PubMed ID: 9865723
[TBL] [Abstract][Full Text] [Related]
3. Radiation therapy to a primary tumor accelerates metastatic growth in mice.
Camphausen K; Moses MA; Beecken WD; Khan MK; Folkman J; O'Reilly MS
Cancer Res; 2001 Mar; 61(5):2207-11. PubMed ID: 11280788
[TBL] [Abstract][Full Text] [Related]
4. Antitumor interaction of short-course endostatin and ionizing radiation.
Hanna NN; Seetharam S; Mauceri HJ; Beckett MA; Jaskowiak NT; Salloum RM; Hari D; Dhanabal M; Ramchandran R; Kalluri R; Sukhatme VP; Kufe DW; Weichselbaum RR
Cancer J; 2000; 6(5):287-93. PubMed ID: 11079167
[TBL] [Abstract][Full Text] [Related]
5. Angiostatin potentiates cyclophosphamide treatment of metastatic disease.
Mauceri HJ; Seetharam S; Beckett MA; Schumm LP; Koons A; Gupta VK; Park JO; Manan A; Lee JY; Montag AG; Kufe DW; Weichselbaum RR
Cancer Chemother Pharmacol; 2002 Nov; 50(5):412-8. PubMed ID: 12439600
[TBL] [Abstract][Full Text] [Related]
6. Combined effects of angiostatin and ionizing radiation in antitumour therapy.
Mauceri HJ; Hanna NN; Beckett MA; Gorski DH; Staba MJ; Stellato KA; Bigelow K; Heimann R; Gately S; Dhanabal M; Soff GA; Sukhatme VP; Kufe DW; Weichselbaum RR
Nature; 1998 Jul; 394(6690):287-91. PubMed ID: 9685160
[TBL] [Abstract][Full Text] [Related]
7. A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer.
Sim BK; O'Reilly MS; Liang H; Fortier AH; He W; Madsen JW; Lapcevich R; Nacy CA
Cancer Res; 1997 Apr; 57(7):1329-34. PubMed ID: 9102221
[TBL] [Abstract][Full Text] [Related]
8. NM-3, an isocoumarin, increases the antitumor effects of radiotherapy without toxicity.
Salloum RM; Jaskowiak NT; Mauceri HJ; Seetharam S; Beckett MA; Koons AM; Hari DM; Gupta VK; Reimer C; Kalluri R; Posner MC; Hellman S; Kufe DW; Weichselbaum RR
Cancer Res; 2000 Dec; 60(24):6958-63. PubMed ID: 11156396
[TBL] [Abstract][Full Text] [Related]
9. The therapeutic efficacy of angiostatin against weakly- and highly-immunogenic 3LL tumors.
Li M; Huang X; Zhu Z; Zhao Q; Wong M; Gorelik E
In Vivo; 2002; 16(6):577-82. PubMed ID: 12494903
[TBL] [Abstract][Full Text] [Related]
10. Suppression of tumor growth with recombinant murine angiostatin.
Wu Z; O'Reilly MS; Folkman J; Shing Y
Biochem Biophys Res Commun; 1997 Jul; 236(3):651-4. PubMed ID: 9245707
[TBL] [Abstract][Full Text] [Related]
11. The tumor-suppressing activity of angiostatin protein resides within kringles 1 to 3.
MacDonald NJ; Murad AC; Fogler WE; Lu Y; Sim BK
Biochem Biophys Res Commun; 1999 Oct; 264(2):469-77. PubMed ID: 10529387
[TBL] [Abstract][Full Text] [Related]
12. Optimal scheduling of interleukin-12 and fractionated radiation therapy in the murine Lewis lung carcinoma.
Teicher BA; Ara G; Buxton D; Leonard J; Schaub RG
Radiat Oncol Investig; 1998; 6(2):71-80. PubMed ID: 9572683
[TBL] [Abstract][Full Text] [Related]
13. Angiostatin induces mitotic cell death of proliferating endothelial cells.
Hari D; Beckett MA; Sukhatme VP; Dhanabal M; Nodzenski E; Lu H; Mauceri HJ; Kufe DW; Weichselbaum RR
Mol Cell Biol Res Commun; 2000 May; 3(5):277-82. PubMed ID: 10964751
[TBL] [Abstract][Full Text] [Related]
14. Antibody-directed targeting of angiostatin's receptor annexin II inhibits Lewis Lung Carcinoma tumor growth via blocking of plasminogen activation: possible biochemical mechanism of angiostatin's action.
Sharma MR; Rothman V; Tuszynski GP; Sharma MC
Exp Mol Pathol; 2006 Oct; 81(2):136-45. PubMed ID: 16643891
[TBL] [Abstract][Full Text] [Related]
15. Increase in efficacy of cancer radiotherapy by combination with whole-body low dose irradiation.
Wu N; Jin SZ; Pan XN; Liu SZ
Int J Radiat Biol; 2008 Mar; 84(3):201-10. PubMed ID: 18300020
[TBL] [Abstract][Full Text] [Related]
16. Combined antiestrogen, antiangiogenic and anti-invasion therapy inhibits primary and metastatic tumor growth in the MMTVneu model of breast cancer.
Sacco MG; Soldati S; Indraccolo S; Cató EM; Cattaneo L; Scanziani E; Vezzoni P
Gene Ther; 2003 Oct; 10(22):1903-9. PubMed ID: 14502219
[TBL] [Abstract][Full Text] [Related]
17. [Study on the antitumor effect of angiostatin on LA795 adenocarcinoma cells].
Zheng F; Tong W; Wen J
Zhonghua Jie He He Hu Xi Za Zhi; 2000 Jan; 23(1):34-6. PubMed ID: 11778179
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of tumor growth by plasminogen-related protein-B.
Lewis VO; O'Reilly MS; Gehrmann M; Llinás M; Schaller J; Weissbach L
Anticancer Res; 2001; 21(4A):2287-91. PubMed ID: 11724284
[TBL] [Abstract][Full Text] [Related]
19. Characterization and biological activities of recombinant human plasminogen kringle 1-3 produced in Escherichia coli.
You WK; So SH; Sohn YD; Lee H; Park DH; Chung SI; Chung KH
Protein Expr Purif; 2004 Jul; 36(1):1-10. PubMed ID: 15177278
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of radiation effects by pXLG-mEndo in a lung carcinoma model.
Luo X; Slater JM; Gridley DS
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):553-64. PubMed ID: 15964154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]